Intensive Care and Critical Care Medicine

  1. Research Status of the Safety and Efficacy of Mesenchymal Stem Cells in the Treatment of COVID-19-Related Pneumonia: A Systematic Review and Meta-Analysis

    1. Junwu Wang
    2. Pengzhi Shi
    3. Dong Chen
    4. Shuguang Wang
    5. Pingchuan Wang
    6. Xinmin Feng
    7. Liang Zhang

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Effects of IFIH1 rs1990760 variants on systemic inflammation and outcome in critically ill COVID-19 patients in an observational translational study

    1. Laura Amado-Rodríguez
    2. Estefania Salgado del Riego
    3. Juan Gomez de Ona
    4. Inés López Alonso
    5. Helena Gil-Pena
    6. Cecilia López-Martínez
    7. Paula Martín-Vicente
    8. Antonio Lopez-Vazquez
    9. Adrian Gonzalez Lopez
    10. Elias Cuesta-Llavona
    11. Raquel Rodriguez-Garcia
    12. Jose Antonio Boga
    13. Marta Elena alvarez-Arguelles
    14. Juan Mayordomo-Colunga
    15. Jose Ramon Vidal-Castineira
    16. Irene Crespo
    17. Margarita Fernandez
    18. Loreto Criado
    19. Victoria Salvadores
    20. Francisco Jose Jimeno-Demuth
    21. Lluis Blanch
    22. Belen Prieto
    23. Alejandra Fernandez-Fernandez
    24. Carlos Lopez-Larrea
    25. Eliecer Coto
    26. Guillermo M Albaiceta

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Heterogeneity of hypoxemia severity according to pulse oximetry and blood gas analysis in COVID-19 pneumonia

    1. I. Núñez
    2. A. Soto-Mota

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Recovery from Covid-19 critical illness: A secondary analysis of the ISARIC4C CCP-UK cohort study and the RECOVER trial

    1. Ellen Pauley
    2. Thomas M Drake
    3. David M Griffith
    4. Louise Sigfrid
    5. Nazir I Lone
    6. Ewen M Harrison
    7. J Kenneth Baillie
    8. Janet T Scott
    9. Timothy S Walsh
    10. Malcolm G Semple
    11. Annemarie B Docherty
    12. on behalf of the ISARIC4C and RECOVER Investigators

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Dysphagic disorder in a cohort of COVID-19 patients: Evaluation and evolution

    1. Samuele Ceruti
    2. Andrea Glotta
    3. Anna Galli
    4. Maira Biggiogero
    5. Giovanni Bona
    6. Romano Mauri
    7. Andrea Saporito
    8. Xavier Capdevila

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Multidisciplinary team approach in critically ill COVID-19 patients reduced pronation-related complications rate: A retrospective cohort study

    1. Samuele Ceruti
    2. Andrea Glotta
    3. Maira Biggiogero
    4. Giovanni Bona
    5. Andrea Saporito
    6. Nicola Faldarini
    7. Diana Olivieri
    8. Claudia Molteni
    9. Stefano Petazzi
    10. Xavier Capdevila

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Effectiveness of Tocilizumab, Sarilumab, and Anakinra for critically ill patients with COVID-19 The REMAP-CAP COVID-19 Immune Modulation Therapy Domain Randomized Clinical Trial

    1. The REMAP-CAP Investigators
    2. Lennie P.G. Derde

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Convalescent Plasma in Critically ill Patients with Covid-19

    1. The REMAP-CAP Investigators
    2. Lise J. Estcourt

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. A functionally distinct neutrophil landscape in severe COVID-19 reveals opportunities for adjunctive therapies

    1. Rachita Panda
    2. Fernanda V.S. Castanheira
    3. Jared M. Schlechte
    4. Bas G.J. Surewaard
    5. Hanjoo Brian Shim
    6. Amanda Z. Zucoloto
    7. Zdenka Slavikova
    8. Bryan G. Yipp
    9. Paul Kubes
    10. Braedon McDonald

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, proof-of-concept trial

    1. Benjamin A Fisher
    2. Tonny Veenith
    3. Daniel Slade
    4. Charlotte Gaskell
    5. Matthew Rowland
    6. Tony Whitehouse
    7. James Scriven
    8. Dhruv Parekh
    9. Madhu S Balasubramaniam
    10. Graham Cooke
    11. Nick Morley
    12. Zoe Gabriel
    13. Matthew P Wise
    14. Joanna Porter
    15. Helen McShane
    16. Ling-Pei Ho
    17. Philip N Newsome
    18. Anna Rowe
    19. Rowena Sharpe
    20. David R Thickett
    21. Julian Bion
    22. Simon Gates
    23. Duncan Richards
    24. Pamela Kearns
    25. Bryan Williams
    26. Rebecca Turner
    27. Vincenzo Libri
    28. Francis Mussai
    29. Gary Middleton
    30. Sarah Bowden
    31. Mansoor Bangash
    32. Fang Gao-Smith
    33. Jaimin Patel
    34. Elizabeth Sapey
    35. Mark Thomas
    36. Mark Coles
    37. Peter Watkinson
    38. Naj Rahman
    39. Brian Angus
    40. Alexander J. Mentzer
    41. Alex Novak
    42. Marc Feldman
    43. Alex Richter
    44. Sian Faustini
    45. Camilla Bathurst
    46. Joseph Van de Wiel
    47. Susie Mee
    48. Karen James
    49. Bushra Rahman
    50. Karen Turner
    51. Adam Hill
    52. Anthony Gordon
    53. Christina Yap
    54. Michael Matthay
    55. Danny McAuley
    56. Andrew Hall
    57. Paul Dark
    58. Andrew McMichael

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 14 of 28 Next